Related references
Note: Only part of the references are listed.Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing
Mohindar M. Karunakaran et al.
IMMUNITY (2020)
Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma
Weilun Fu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
Bas Weenink et al.
CANCERS (2020)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy
Ghita Chabab et al.
FRONTIERS IN IMMUNOLOGY (2020)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2020)
A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis
Yanding Zhao et al.
MOLECULAR CANCER RESEARCH (2019)
Immune microenvironments differ in immune characteristics and outcome of glioblastoma multiforme
Botao Zhang et al.
CANCER MEDICINE (2019)
Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics
Artemiy S. Silantyev et al.
CELLS (2019)
Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells
Vinicia A. Polito et al.
FRONTIERS IN IMMUNOLOGY (2019)
Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme
Mijeong Lee et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dendritic cells cross-talk with tumour antigen-specific CD8+ T cells, V9T cells and V24NKT cells in patients with glioblastoma multiforme and in healthy donors
Y. Eiraku et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert et al.
LANCET ONCOLOGY (2018)
γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
Elena Lo Presti et al.
FRONTIERS IN IMMUNOLOGY (2018)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
NKG2D-and T-cell receptor-dependent lysis of malignant glioma cell lines by human T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
Guranda Chitadze et al.
ONCOIMMUNOLOGY (2016)
The combination of bleomycin with suicide or interferon-β gene transfer is able to efficiently eliminate human melanoma tumor initiating cells
Chiara Fondello et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo
Tsutomu Nakazawa et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors
Ulrich Jarry et al.
ONCOIMMUNOLOGY (2016)
Glioblastoma: pathology, molecular mechanisms and markers
Kenneth Aldape et al.
ACTA NEUROPATHOLOGICA (2015)
Human Vγ9/Vδ2 T cells: Innate adaptors of the immune system
Christopher J. Tyler et al.
CELLULAR IMMUNOLOGY (2015)
Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery
Olesja Fornara et al.
ONCOIMMUNOLOGY (2015)
Synthesis of a Phosphoantigen Prodrug that Potently Activates Vγ9Vδ2 T-Lymphocytes
Chia-Hung Christine Hsiao et al.
CHEMISTRY & BIOLOGY (2014)
gamma delta T cells for cancer immunotherapy A systematic review of clinical trials
Jonathan P. H. Fisher et al.
ONCOIMMUNOLOGY (2014)
EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
Krishna M. Talasila et al.
ACTA NEUROPATHOLOGICA (2013)
Repeated Systemic Administrations of Both Aminobisphosphonates and Human Vγ9Vδ2 T Cells Efficiently Control Tumor Development In Vivo
Thibault Santolaria et al.
JOURNAL OF IMMUNOLOGY (2013)
Action of Shiga Toxin Type-2 and Subtilase Cytotoxin on Human Microvascular Endothelial Cells
Maria M. Amaral et al.
PLOS ONE (2013)
Tumor cell recognition by γδ T lymphocytes T-cell receptor vs. NK-cell receptors
Daniel V. Correia et al.
ONCOIMMUNOLOGY (2013)
ZOLEDRONIC ACID ENHANCES V delta 2 T-LYMPHOCYTE ANTITUMOR RESPONSE TO HUMAN GLIOMA CELL LINES
E. Cimini et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
Olivier Keunen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Preferential Th1 Cytokine Profile of Phosphoantigen-Stimulated Human V gamma 9V delta 2T Cells
Margaret R. Dunne et al.
MEDIATORS OF INFLAMMATION (2010)
Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
Nichole L. Bryant et al.
NEURO-ONCOLOGY (2009)
V gamma 9V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs - Rituximab and trastuzumab
Hirotake Tokuyama et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Preferential recognition of a microbial metabolite by human Vγ2Vδ2 T cells
Kia-Joo Puan et al.
INTERNATIONAL IMMUNOLOGY (2007)
Patterns of chemokine receptor expression on peripheral blood γδ T lymphocytes:: Strong expression of CCR5 is a selective feature of Vδ2/Vγ9 γδ T cells
A Glatzel et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
